Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

Healthcare Medical Instruments & Supplies
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

InspireMD Announces Distribution Agreement for CGuard EPS in Taiwan

Marketwired June 8, 2017

InspireMD Announces the Publication of an Investigator Initiated Clinical Registry Reaffirming MGuard(TM) Prime as a Highly Effective Tool to Prevent Heart Damage in Coronary Artery Blockages with High Thrombotic Content

Marketwired June 7, 2017

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Poland

Marketwired June 5, 2017

InspireMD Announces Appointment of Paul Stuka as Chairman of the Board

Marketwired June 2, 2017

InspireMD to Present at the 6th Annual SeeThruEquity Microcap Investor Conference

Accesswire May 31, 2017

InspireMD Announces First Two Patients in Hong Kong Successfully Treated with CGuard EPS

Marketwired May 30, 2017

Research Reports Initiation on Medical Equipment Stocks -- Corindus Vascular Robotics, InspireMD, Xtant Medical, and Second Sight Medical Products

PR Newswire May 23, 2017

InspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case Transmission at EuroPCR 2017

Accesswire May 18, 2017

InspireMD Announces Publication of the IRON-GUARD Registry in EuroIntervention

Accesswire May 17, 2017

InspireMD Announces Distribution Agreements for CGuard(TM) EPS and MGuard Prime(TM) EPS in Peru and Ecuador

Accesswire May 15, 2017

InspireMD Provides Business Update for the First Quarter of 2017

Accesswire May 9, 2017

InspireMD Schedules First Quarter 2017 Earnings Conference Call

Accesswire May 5, 2017

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Germany

Accesswire May 1, 2017

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in the Netherlands

Accesswire April 6, 2017

InspireMD Announces Listing of Series B Warrants on the NYSE MKT

Accesswire April 5, 2017

InspireMD Announces Distribution Agreement for CGuardTM in Turkey

Accesswire April 4, 2017

InspireMD Announces Commercial Launch of CGuard(TM) EPS in the Russian Federation at the ICCA Stroke Event in Moscow

Accesswire March 30, 2017

InspireMD's CGuard(TM) Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

Accesswire March 23, 2017

InspireMD Repays Term Note Ahead of Schedule

Accesswire March 22, 2017

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Hong Kong

Accesswire March 21, 2017